Results 131 to 140 of about 819,739 (287)

Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma

Arthritis Care &Research, EarlyView.
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim, John Scott, Lauren Fisher, Lauren N. Smith, Willie Stewart, Adrianne Woods, Rob Smithwright, Diane Koher, Parastoo Aslanbeik, Aalok B. Shah, Brad Tibbils, Samantha I. Pitts, Ayse P. Gurses, Yushi Yang, Ana‐Maria Orbai, Antony Rosen, Laura K. Hummers, Scott L. Zeger, Ami A. Shah   +18 more
wiley   +1 more source

Publication Bias: For How Much Longer? [PDF]

Am J Respir Crit Care Med
de Benedictis FM.
europepmc   +1 more source

Hydroxychloroquine Associated With Lower Glomerular Filtration Rate Decline in Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical.
Shivani Garg, Brad Rovin, Brad C. Astor, Tripti Singh, Fauzia Hollnagel, Megan Kuik, Lexie Kolton, Callie Saric, S. Sam Lim, Christie M. Bartels   +9 more
wiley   +1 more source

Global and Regional Temporal Changes in Cross‐Country Inequalities of Site‐Specific Osteoarthritis Burden, 1990 to 2021

Arthritis Care &Research, EarlyView.
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rates (ASYRs) for site‐specific OA across 204 countries and territories were obtained from the Global Burden of Diseases, Injuries, and ...
Haowei Chen, Lei Si, David J. Hunter, Lei Zhang, Zhe‐Sheng Chen, Xiaomeng Wang, Vicky Duong, Zhounan Zhou, Peihua Cao, Han Cen, Su'an Tang, Tianyu Chen, Houjun Xue, Zhaohua Zhu, Changhai Ding   +14 more
wiley   +1 more source

Systematic review of Aedes aegypti control trials suggests publication bias related to author disclosure of conflicts of interest. [PDF]

PLoS Negl Trop Dis
Abdi AA, Juarez JG, Harris T, Magalhaes T, Hamer GL.   +4 more
europepmc   +1 more source

Tests for publication bias are unreliable in case of heteroscedasticity. [PDF]

Contemp Clin Trials Commun, 2021
Almalik O, Zhan Z, van den Heuvel ER.
europepmc   +1 more source

ASSESSING EFFECT SIZE, HETEROGENEITY AND PUBLICATION BIAS IN STUDIES ON THE EFFECT OF FORMATIVE ASSESSMENT ON STUDENTS' ACADEMIC ACHIEVEMENT IN SCIENCE SUBJECTS IN NIGERIA: A META-ANALYTIC INVESTIGATION

International Journal of Progressive Trends and Studies in Education
openalex   +1 more source

Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial

Arthritis Care &Research, EarlyView.
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry, Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Kaleb Michaud, Bridget Kramer, Jeff A. Newcomb, Mary T. Brophy, Anne Davis‐Karim, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, James R. O'Dell, Ted R. Mikuls   +16 more
wiley   +1 more source

Ending publication bias: A values-based approach to surface null and negative results. [PDF]

PLoS Biol
Curry S, Mercado-Lara E, Arechavala-Gomeza V, Begley CG, Bernard C, Bernard R, Bertuzzi S, Bhalla N, Bowers D, Brod S, Chambers C, Dougherty MR, Bueso YF, Forner S, Freeman ALJ, Haas M, Henderson DP, Khanna K, Lawrence R, Liakath-Ali K, Liu C, Malhotra N, Merino JG, Miguel E, Miles R, Munson M, Nakagawa S, Nobles R, Owango J, Pham MT, Poe G, Ramirez AN, Sarabipour S, Silverman JL, Smith LN, Sriramarao P, Sternberg PW, Swamy GK, Tansey MG, Torres GE, Turner EH, von Klinggraeff L, Weis-Garcia F.   +42 more
europepmc   +1 more source

Publication bias in trials registered in the Australian New Zealand Clinical Trials Registry: Is it a problem? A cross-sectional study. [PDF]

PLoS One, 2023
Showell M, Buckman S, Berber S, Ata Allah N, Patterson B, Cole S, Farquhar C, Jordan V.   +7 more
europepmc   +1 more source